Perspectives

Refining endoscopic surveillance beyond average-risk screening

• by Gyanprakash A. Ketwaroo, MD, MSc, Isaiah T. Gonzalez, MD, Mimi C. Tan, MD, MPH, Samir A. Shah, MD

Drs. Isaiah Gonzalez and Mimi Tan offer a thoughtful framework for the evaluation and surveillance of gastric intestinal metaplasia, while Dr. Samir A. Shah provides a practical and evidence-based approach to IBD surveillance, highlighting his use of chromoendoscopy with targeted sampling to improve dysplasia detection.

GI experts debate ESG, GLP-1 roles in modern obesity treatment strategies

• by Gyanprakash A. Ketwaroo, MD, MSc, Marianna T. Papademetriou, MD, Dan Maselli, MD, D-ABOM, Eric J. Vargas, MD, MS, D-ABOM

Dr. Marianna Papademetriou makes a strong case for embracing medical weight loss medications. Drs. Eric Vargas and Dan Maselli counter with an equally compelling defense of ESG, arguing that endobariatrics remains a vital, underused tool.

Index of Severity for Eosinophilic Esophagitis: Growing body of evidence supports use

• by Andrew Dickerson, MD , Corey Ketchem, MD, Carey Cotton, MD, Tetsuo Shoda, MD, PhD

I-SEE aims to provide a more comprehensive assessment that goes beyond eosinophil counts to include symptom frequency, complications, and signs of remodeling.

Approach to weight management in GI practice

• by Colleen R. Kelly, MD

As gastroenterologists, we treat a number of conditions that are caused or worsened by obesity.

“So you have an idea...”

• by Alicia Muratore, MD, MBA, Emily V. Wechsler, MD, Eric D. Shah, MD, MBA

A practical guide to tech and device development for the early-career GI

AI in gastroenterology and endoscopy

• by Gyanprakash A. Ketwaroo, MD, MSc, Yuvaraj Singh, MD, Alessandro Colletta, MD, Dennis L. Shung, MD, MHS, PhD, Neil Marya, MD

AI tools that were once conceptual are now entering everyday practice,

Evolving standards of practice: esophageal varices and Barrett’s esophagus

• by Gyanprakash A. Ketwaroo, MD, MSc, Tarek Sawas, MD, Anahita Rabiee, MD

GLP-1 receptor agonist use in gastrointestinal endoscopy: A review of current evidence and guidelines

• by Sitharthan Sekar, MD, Nikiya Asamoah, MD

Although there is little data to guide clinicians, several recent studies can direct clinical decision-making as guidelines continue to be refined and updated.

An approach to exocrine pancreatic insufficiency: Considerations in diagnosis and treatment

• by Yasmin G. Hernandez-Barco, MD, Motaz Ashkar, MBBS, MSCI

Symptoms are often the most common reason to test for disease state in the appropriate clinical context.

Practical tips on delivering feedback to trainees and colleagues

• by Michelle Baliss DO, Christine Hachem, MD

"Tried and true” practical tips on delivering feedback and on navigating potential barriers based on lessons learned.

Treating Barrett’s esophagus: Comparing EMR and ESD

• by Gyanprakash A. Ketwaroo, MD, MSc, Mohamed O. Othman, MD, AGAF, Silvio W. De Melo Jr., MD, AGAF

How do we incorporate ESD into our algorithm for management?

A practical approach to diagnosis and management of eosinophilic esophagitis

• by Evan S. Dellon, MD, MPH

Eosinophilic esophagitis can be considered a “young” disease, with initial case series reported only about 30 years ago.

Surgical vs endoscopic excision of large colon polyps

• by GI and Hepatology News, Gyanprakash A. Ketwaroo, MD, MSc, Moamen Gabr, MD, MSC, Jeffrey D. Mosko, MD, MSc, Ira Leeds, MD

Are there specific polyps for which we should consult a surgeon first?

Clinical research in early career academic medicine

• by Lauren D. Feld, MD, Kathy Nguyen, Katherine Cooper, MD, Loren Galler Rabinowitz, MD, Amiko M. Uchida, MD

Many exciting opportunities and notable barriers exist to establishing a clinical research laboratory in the early career.

Treating GERD: Lifestyle modifications vs medication

• by Gyanprakash A. Ketwaroo, MD, MSc, Juan D. Gomez, MD, Brijesh B. Patel, MD

While PPIs are highly effective, concerns about their potential side effects frequently make headlines.

Alternative paths to recertification

• by Gyanprakash A. Ketwaroo, MD, MSc, Petr Protiva, MD, MPH, AGAF, Maggie Ham, MD, AGAF

GIs discuss experiences with differing assessment methods.

A simplified approach to pelvic floor dysfunction

• by Ayesha Khan, DO, Raakhi Menon, DO, Lindsay Allen, PT, DPT, MBA, Brooke Corning, MD

Symptoms related to PFD are common concerns raised by patients to GIs.

Achieving promotion for junior faculty in academic medicine: An interview with experts

• by Vineet S. Rolston, MD, Sophie Balzora, MD, Mark A. Schattner, MD

Opting for a career in academic medicine can offer benefits such as increased autonomy and scheduling flexibility.

The breakthrough drug whose full promise remains unrealized

• by Nancy S. Reau, MD

Without increased screening and linkage to curative therapy, we will not meet the WHO goals for HCV elimination.

Eosinophilic esophagitis: A year in review

• by Joan W. Chen, MD, MS

Diet remains the only therapy targeting the cause of EoE and offers a potential drug-free remission.

Surveillance colonoscopy: When and how to stop

• by GI and Hepatology News

Drs. Petr Protiva and Mariam Naveed address this issue and provide differing perspectives on approaching surveillance colonoscopy in the elderly.